|
2021
|
Invention
|
Therapeutic rna for hpv-positive cancer. This disclosure relates to the field of therapeutic RNA ... |
|
|
Invention
|
Rna replicon for versatile and efficient gene expression. The present invention embraces an RNA r... |
|
|
Invention
|
Lipid particle formulations for delivery of rna and water-soluble therapeutically effective compo... |
|
2020
|
Invention
|
Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer p... |
|
|
Invention
|
Individualized vaccines for cancer. The present invention relates to the provision of vaccines wh... |
|
|
Invention
|
Monoclonal antibodies against claudin-18 for treatment of cancer. The present invention provides ... |
|
|
Invention
|
Stabilization of poly(a) sequence encoding dna sequences. E. coli, methods of obtaining RNA, pept... |
|
|
Invention
|
Therapeutic rna for prostate cancer. Disclosed herein are compositions, uses, and methods for tre... |
|
|
Invention
|
Diagnosis and therapy of cancer involving cancer stem cells. The present invention provides metho... |
|
2019
|
Invention
|
Rna formulation for immunotherapy. The present invention is in the field of immunotherapy, in par... |
|
|
Invention
|
Formulation for administration of rna. The present invention relates to compositions comprising p... |
|
2018
|
Invention
|
Individualized vaccines for cancer. The present invention relates to a patient-specific tumor tre... |
|
|
Invention
|
Antibodies against claudin 18.2 useful in cancer diagnosis. The invention relates to antibodies d... |
|
2017
|
Invention
|
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy. The pre... |
|
2016
|
Invention
|
Novel cytokine fusion proteins. The present invention relates to cytokine fusion proteins and to ... |
|
|
Invention
|
3′-utr sequences for stabilization of rna. The present invention relates to stabilization of RNA,... |
|
|
Invention
|
3' utr sequences for stabilization of rna. The present invention relates to stabilization o... |
|
|
Invention
|
3' utr sequences for stabilization of rna. The present invention relates to stabilization of RNA,... |
|
|
Invention
|
Methods for prediction of therapeutic efficacy and survival-free progression of cldn18.2-positive... |
|
|
Invention
|
Drug conjugates comprising antibodies against claudin 18.2. The present invention provides ... |
|
|
Invention
|
Predicting t cell epitopes useful for vaccination. The present invention relates to methods for p... |
|
|
Invention
|
Cytokine fusion proteins. The present invention relates to cytokine fusion proteins and to nuclei... |
|
2015
|
Invention
|
Antigen receptors and uses thereof. The present invention generally embraces the treatment of dis... |
|
|
Invention
|
Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof. The present inven... |
|
|
Invention
|
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination. The present ... |
|
|
Invention
|
Claudin-18.2-specific immunoreceptors and t cell epitopes. The present invention provides Claudin... |
|
|
Invention
|
Drug conjugates comprising antibodies against claudin 18.2. The present invention provides anti-C... |
